combination therapies outperforming semaglutide A 72-week trial compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the A secret shopper study found

supply is research-grade rather than pharmaceutical-grade

Improved energy, blood sugar, and cholesterol levels often accompany semaglutide treatment, enhancing overall health and contributing to reduced risks of heart-related conditions

The medication is HSA/FSA eligible and available in all 50 states without insurance or membership fees

Let me ask you something

Benefits of Ozempic & Wegovy (Semaglutide) Reduced appetite and fewer cravings Improved portion control Gradual, medically supervised weight loss Potential improvement in metabolic markers Support for long-term lifestyle changes Individual results vary

But hey better than gaining